Where Is the "Optimal" Fontan Hemodynamics?

Hideo Ohuchi1

  • 1Departments of Pediatric Cardiology and Adult Congenital Heart Disease, National Cerebral and Cardiovascular Center, Suita, Japan. hohuchi@hsp.ncvc.go.jp.

Insights

Fontan circulation management aims for smooth adjustment and long-term stabilization. Understanding failing Fontan hemodynamics is crucial for improving outcomes in survivors with congenital heart disease.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Fontan circulation presents unique hemodynamic challenges, differing significantly from normal biventricular physiology.
  • Achieving smooth adjustment and long-term hemodynamic stabilization are critical goals in Fontan circulation therapy.
  • Failure to meet these goals leads to "failed" Fontan circulation with poor prognosis.

Purpose of the Study:

  • To investigate the clinical and hemodynamic characteristics of early and late failing Fontan survivors.
  • To explore the association between these characteristics and all-cause mortality.
  • To provide insights into Fontan pathophysiology for improved long-term management strategies.

Main Methods:

  • Retrospective analysis of clinical data from Fontan survivors.
  • Detailed hemodynamic assessment in patients experiencing Fontan failure.
  • Statistical analysis to correlate clinical and hemodynamic factors with mortality.

Main Results:

  • Identified distinct clinical and hemodynamic profiles for early versus late Fontan failure.
  • Established a significant association between specific hemodynamic parameters and all-cause mortality.
  • Highlighted the complexity of Fontan pathophysiology and its impact on long-term outcomes.

Conclusions:

  • Understanding the characteristics of failing Fontan circulation is essential for developing effective management strategies.
  • Further research into optimal hemodynamics is needed to guide patient care and improve survival.
  • This study provides valuable data for establishing a management framework for long-term hemodynamic stabilization in Fontan survivors.